Don't just listen to us, trust what our partners say about us! A fantastic recommendation from one of Zac Cisotti's clients: "Zac is one of the finest talent acquisition partners I’ve worked with in my professional career. His ability to listen and truly understand the needs of his clients sets him apart from many of the other firms in this space. I’ve been extremely pleased with the results he has been able to deliver while building a true partnership for the long term. I’d highly recommend him and his team." Contact Zac on +44 (0)20 3854 7700. #testimonial #financerecruitment #pharmarecruitment
Mantell Associates
Executive Search Services
City of London, England 86,357 followers
Multidiscipline Global Life Science and Pharmaceutical Headhunting Firm.
About us
Mantell Associates is a multi-discipline headhunting firm focused on providing both permanent and contract recruitment services globally, to the Biotech, Pharmaceutical, CDMO, CRO, Diagnostics, Animal Health, Consulting, Medical Device and MedTech sectors. With success ranging across C-Suite, Commercial, Technical Operations, Scientific, Clinical, Quality and Regulatory, we pride ourselves on our ability to bring the top talent to our clients, and the best opportunities to the top talent. Our services span across our Partnership Service, Contingency, Project Management and Contract models, meaning that we can cater to our client’s every requirement.
- Website
-
www.mantellassociates.com
External link for Mantell Associates
- Industry
- Executive Search Services
- Company size
- 51-200 employees
- Headquarters
- City of London, England
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Contract Development Manufacturing Organisations, Contract Manufacturing Organisations, Preclinical, Active Pharmaceutical Ingredients, Cell & Gene Therapy, Finished Dosage Forms, Biologics, Toxicology, Pharmacology, Oncology, CDMO, CMO, Biomarkers, Vaccines, Contract Research Organisation, Clinical Trial Supplies, Bioanalytics, Bioanalysis, Fine Chemicals, and Highly Potent Active Pharmaceutical Ingredients
Locations
-
Primary
150 Minories
City of London, England EC3N 1LS, GB
-
2 S Biscayne Blvd
Miami, Florida 33131, US
-
Rigistrasse 3
Zug, 6300, CH
Employees at Mantell Associates
Updates
-
Regeneron has secured European Commission (EC) approval for Ordspono (odronextamab) to treat relapsed or refractory (R/R) follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). Read more below: https://lnkd.in/e4YhpVTF #drugapproval #cancertreatment #drugfunding
-
Hvar High Rollers 2024! Last week our top performers spent 4 days in Hvar, Croatia as part of our all-expenses-paid High Rollers incentive. An amazing trip filled with incredible food including a private chef, beach clubs, a chartered boat and private villa in the port of Hvar. Not only did Hvar have the most beautiful settings, it was a great few days bonding as a team. Huge congratulations to everyone who qualified! #recruitmentincentives #recruitmentlondon #recruitment
-
+6
-
Tanvex Biopharma USA, Inc., a CDMO for biologics and a biosimilars products company, has received U.S. FDA approval for Nypozi (filgrastim-txid), the company's biosimilar referencing Neupogen,1, to treat chemotherapy-induced neutropenia in cancer patients. Read more below: https://lnkd.in/eHA93547 #regulatorynews #biopharma #pharmanews
Tanvex BioPharma USA Achieves Dual U.S. Regulatory Milestones
contractpharma.com
-
Happy Labor Day to our wide network of colleagues, candidates and clients across the US. We hope you enjoy today celebrating with family and friends! #laborday #recruitmentus #network
-
Novartis’ blood cancer sculpture tour has reached a new destination. The Swiss drugmaker, which put the sculptures on show in London one year ago, is marking this year’s Blood Cancer Awareness Month by setting up the artwork at the University of Glasgow. https://lnkd.in/e7kzJWc3 #bloodcancer #cancerawareness #pharmanews
Novartis brings blood cancer sculptures to Scotland, continuing symptom awareness tour
fiercepharma.com
-
Sanyou Biopharmaceuticals has introduced the "Sanyou Innovative Intelligent Antibody Design oneClick+ Platform," an artificial intelligence-powered platform designed to expedite antibody development. The platform incorporates a vast database of antibody structures, enabling researchers to efficiently design and analyse potential antibody candidates. Read more: https://lnkd.in/e4BT8WRC #artificialintelligence #aipowered #antibodydevelopment
Sanyou Bio Launches AI-Powered Antibody Design Platform
contractpharma.com
-
Apply now! Senior FP&A Manager - Biotech - UK. Mantell Associates is partnered with a leading Life Science organisation, in their search for a Senior Manager of Financial Planning & Analysis (FP&A) to play a critical role in driving strategic financial decision-making. Apply for this role online - https://lnkd.in/eFea25yy - or contact Zac Cisotti on +44 (0)20 3854 7700. #fpajobs #financejobs #financemanager
Senior Manager, Financial Planning & Analysis (FP&A) – Biotech
https://www.mantellassociates.com
-
We have reached our next milestone of 85,000 followers on LinkedIn! Thank you to all our clients, candidates and wider network who have followed our journey since 2019. We look forward to continuing to connect with you all, providing industry insights and news as well as incredible opportunities within the Pharmaceutical and Life Science space. #followers #milestone #recruitment
-
Visiox Pharmaceuticals Inc. has entered into a definitive merger agreement with Ocuvex Therapeutics Inc., a privately held ophthalmic pharmaceutical company that boasts a robust pipeline of near-term ophthalmic medicines. Together they aim to emerge as a leader in the eye care sector with a strong portfolio of ophthalmic medicines. Read more: https://lnkd.in/edw4XXCH #ophthalmic #eyecare #ophthalmicmedicines
Visiox and Ocuvex Merge to Form Ophthalmic Powerhouse
contractpharma.com